2016 Q4 Form 10-Q Financial Statement

#000114420416132831 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $1.028M $1.081M $1.261M
YoY Change -13.54% -14.27% 21.01%
Cost Of Revenue $1.029M $1.033M $1.178M
YoY Change -11.45% -12.3% 7.38%
Gross Profit -$1.000K $48.00K $83.00K
YoY Change -103.33% -42.17% -251.45%
Gross Profit Margin -0.1% 4.44% 6.58%
Selling, General & Admin $1.376M $1.451M $1.030M
YoY Change -0.22% 40.86% 10.8%
% of Gross Profit 3022.92% 1241.12%
Research & Development $150.0K $172.0K $143.9K
YoY Change 158.62% 19.52% -18.52%
% of Gross Profit 358.33% 173.38%
Depreciation & Amortization $20.00K $16.00K $136.7K
YoY Change -85.46% -88.29% -19.59%
% of Gross Profit 33.33% 164.66%
Operating Expenses $1.478M $1.623M $1.174M
YoY Change 2.85% 38.24% 6.12%
Operating Profit -$1.479M -$1.575M -$1.091M
YoY Change 4.89% 44.42% -6.07%
Interest Expense $30.00K $60.00K $950.00
YoY Change 6215.79% -72.47%
% of Operating Profit
Other Income/Expense, Net $29.00K $77.00K $71.47K
YoY Change -70.71% 7.74% -80.95%
Pretax Income -$1.450M -$1.500M -$1.020M
YoY Change 10.69% 47.06% 29.11%
Income Tax
% Of Pretax Income
Net Earnings -$1.450M -$1.498M -$1.019M
YoY Change 10.52% 47.01% 29.67%
Net Earnings / Revenue -141.05% -138.58% -80.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$26.35K -$27.27K -$18.54K
COMMON SHARES
Basic Shares Outstanding 55.02M shares 55.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.95M $13.71M $13.48M
YoY Change -5.16% 1.71% 11.4%
Cash & Equivalents $6.668M $8.459M $1.588M
Short-Term Investments $5.280M $5.250M $11.89M
Other Short-Term Assets $220.0K $260.0K $260.0K
YoY Change 0.0% 0.0% 4.0%
Inventory $380.0K $380.0K $460.6K
Prepaid Expenses
Receivables $630.0K $570.0K $1.130M
Other Receivables $0.00 $0.00 $10.41K
Total Short-Term Assets $13.18M $14.93M $15.34M
YoY Change -7.73% -2.68% 11.75%
LONG-TERM ASSETS
Property, Plant & Equipment $779.0K $700.0K $441.9K
YoY Change 132.02% 58.41% -48.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $5.140M
YoY Change -100.0% -100.0% -48.86%
Other Assets $278.0K $770.0K $240.4K
YoY Change 19.31% 220.3% -7.05%
Total Long-Term Assets $1.806M $1.760M $6.569M
YoY Change -72.05% -73.21% -44.39%
TOTAL ASSETS
Total Short-Term Assets $13.18M $14.93M $15.34M
Total Long-Term Assets $1.806M $1.760M $6.569M
Total Assets $14.99M $16.69M $21.91M
YoY Change -27.76% -23.82% -14.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $310.0K $490.0K $410.0K
YoY Change -54.41% 19.51% -19.61%
Accrued Expenses $560.0K $630.0K $520.0K
YoY Change 40.0% 21.15% 10.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $871.0K $1.120M $931.4K
YoY Change -19.26% 20.25% -4.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $550.0K $590.0K $1.140M
YoY Change -50.45% -48.25% 0.0%
Total Long-Term Liabilities $550.0K $590.0K $1.140M
YoY Change -50.45% -48.25% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $871.0K $1.120M $931.4K
Total Long-Term Liabilities $550.0K $590.0K $1.140M
Total Liabilities $1.418M $1.710M $2.067M
YoY Change -35.34% -17.26% -2.3%
SHAREHOLDERS EQUITY
Retained Earnings -$69.39M -$67.94M -$62.75M
YoY Change 8.32% 8.27% 6.65%
Common Stock $82.96M $82.91M $55.01K
YoY Change 0.4% 150612.55% 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K
YoY Change 0.0%
Treasury Stock Shares 13.20K shares
Shareholders Equity $13.57M $14.97M $19.84M
YoY Change
Total Liabilities & Shareholders Equity $14.99M $16.69M $21.91M
YoY Change -27.76% -23.84% -14.22%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.450M -$1.498M -$1.019M
YoY Change 10.52% 47.01% 29.67%
Depreciation, Depletion And Amortization $20.00K $16.00K $136.7K
YoY Change -85.46% -88.29% -19.59%
Cash From Operating Activities -$1.660M -$1.353M -$1.110M
YoY Change 104.94% 21.89% -2.63%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K $147.0K $4.000K
YoY Change 200.0% 3575.0% -46.33%
Acquisitions
YoY Change
Other Investing Activities -$30.00K -$30.00K -$2.560M
YoY Change -40.0% -98.83% -45.18%
Cash From Investing Activities -$120.0K -$327.0K -$2.580M
YoY Change 50.0% -87.33% -44.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K 0.000 50.00K
YoY Change 0.0% -100.0% -77.27%
NET CHANGE
Cash From Operating Activities -1.660M -1.353M -1.110M
Cash From Investing Activities -120.0K -327.0K -2.580M
Cash From Financing Activities -10.00K 0.000 50.00K
Net Change In Cash -1.790M -1.680M -3.640M
YoY Change 98.89% -53.85% -35.0%
FREE CASH FLOW
Cash From Operating Activities -$1.660M -$1.353M -$1.110M
Capital Expenditures -$90.00K $147.0K $4.000K
Free Cash Flow -$1.570M -$1.500M -$1.114M
YoY Change 101.28% 34.65% -2.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
55000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
55000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82858000 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82788000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67940000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66442000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
14973000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
16401000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16685000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18102000 USD
CY2016Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000 USD
CY2015Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1501000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1023000 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55011000 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55013000 shares
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16000 USD
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
137000 USD
CY2016Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 USD
CY2015Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10000 USD
CY2015Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
21000 USD
CY2016Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7000 USD
CY2015Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
21000 USD
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
70000 USD
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
32000 USD
CY2016Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31000 USD
CY2015Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81000 USD
CY2016Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39000 USD
CY2015Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
57000 USD
CY2016Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-41000 USD
CY2015Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14000 USD
CY2016Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-118000 USD
CY2015Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-87000 USD
CY2016Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
28000 USD
CY2015Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
28000 USD
CY2016Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12000 USD
CY2015Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12000 USD
CY2016Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
98000 USD
CY2015Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-83000 USD
CY2016Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
11000 USD
CY2015Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-31000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1353000 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1109000 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000 USD
CY2015Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2016Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
151000 USD
CY2015Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
16000 USD
CY2016Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2015Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3527000 USD
CY2016Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
29000 USD
CY2015Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6084000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-327000 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2577000 USD
CY2016Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2015Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
47000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1680000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3639000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5227000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1588000 USD
CY2016Q3 isr Federal Deposit Insurance Corporation Limits On Deposits In Financial Institutions
FederalDepositInsuranceCorporationLimitsOnDepositsInFinancialInstitutions
250000 USD
CY2016Q3 us-gaap Interest Paid
InterestPaid
USD
CY2015Q3 us-gaap Interest Paid
InterestPaid
USD
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
194000 USD
CY2016Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
155000 USD
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
164000 USD
CY2016Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
161000 USD
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22000 USD
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18000 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8243000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8118000 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7540000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7541000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
70000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
732000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M2D
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
230087 shares
CY2016Q3 isr Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0 shares
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
230087 shares
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.94
CY2016Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.94
CY2016Q3 isr Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights
Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights
0
CY2016Q3 dei Document Type
DocumentType
10-Q
CY2016Q3 dei Amendment Flag
AmendmentFlag
false
CY2016Q3 dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
CY2016Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q3 dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
CY2016Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2016Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2016Q3 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q3 dei Trading Symbol
TradingSymbol
ISR
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55017419 shares
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 USD
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55010619 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55010619 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55010619 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55010619 shares
CY2016Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
20000 USD
CY2015Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2016Q3 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">2.</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">New Accounting Pronouncements</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, "Revenue from Contracts with Customers" (ASU 2014-09), which supersedes the revenue recognition requirements in FASB Accounting Standards Codification (ASC) Topic 605, "Revenue Recognition". The guidance requires that an entity recognize revenue in a way that depicts the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The guidance will be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period and is to be applied retrospectively, with early application not permitted. The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2019. This update is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In July 2015, the FASB issued ASU No. 2015-11: Inventory. The guidance requires an entity&#8217;s management to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early application is permitted.&#160; The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2018.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In November 2015, the FASB issued an ASU 2015-17 to simplify the balance sheet classification of deferred taxes. This update requires all deferred tax assets and liabilities to be reported as non-current in the consolidated balance sheets. This update will be effective as of the beginning of fiscal 2018. This update is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In February 2016, the FASB issued ASU 2016-02 Leases (Subtopic 842), which will require lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for annual and interim reporting periods beginning after December 15, 2018. The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2019.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. Except to indicate an evaluation of a recent pronouncement is in process, the Company&#160;does not discuss recent pronouncements that are not anticipated to have potential impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M13D
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2609189 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2530789 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1629996 shares
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y22D
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M26D
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
141677 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
141677 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
139802 USD
CY2016Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
3537500 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10139000 USD
CY2016Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
27000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8459000 USD
CY2016Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
0 USD
CY2016Q3 isr Accrued But Undeclared Dividends
AccruedButUndeclaredDividends
8000 USD
CY2015Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
45994 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
21654 USD
CY2016Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2015Q3 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
3000 USD
CY2015Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
3000 USD
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2898000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2784000 shares

Files In Submission

Name View Source Status
0001144204-16-132831-index-headers.html Edgar Link pending
0001144204-16-132831-index.html Edgar Link pending
0001144204-16-132831.txt Edgar Link pending
0001144204-16-132831-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20160930.xml Edgar Link completed
isr-20160930.xsd Edgar Link pending
isr-20160930_cal.xml Edgar Link unprocessable
isr-20160930_def.xml Edgar Link unprocessable
isr-20160930_lab.xml Edgar Link unprocessable
isr-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v452265_10q.htm Edgar Link pending
v452265_ex10-1.htm Edgar Link pending
v452265_ex31-1.htm Edgar Link pending
v452265_ex31-2.htm Edgar Link pending
v452265_ex32.htm Edgar Link pending